• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 4.5MM X 17MM - PMAS; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 4.5MM X 17MM - PMAS; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Catalog Number FDS45017
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Visual Disturbances (2140)
Date of Event 09/14/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H3 other text : the subject device is implanted inside the patient's vasculature.
 
Event or Problem Description
It was reported that, the subject flow diverter stent was successfully implanted in the patient on (b)(6) 2023.Post procedure on (b)(6) 2023 patient experienced blurred vision in the right eye.The rationale for relationship to the study device was indicated as: "the stent covered the ophthalmic nerve".It is indicated that the blurred vision is possibly related to the study procedure and the study device.The adverse event outcome is indicated as recovering/resolving and no treatment was provided to the patient for this adverse event.The mrs (modified rankin score) & nihss (national institute of health stroke scale) score noted was '0' at discharge on (b)(6) 2023.The mrs score of 1, nihss score of 3 score was noted on (b)(6) 2023.It is noted that the patient has a past medical history of hypertension, former smoker, localized headache, severe head trauma, depression/anxiety, diabetes, hearing loss, budd-chiari syndrome, kyphoscoliosis, peripheral venous insufficiency and craniotomy.
 
Additional Manufacturer Narrative
Due to the automated mes (manufacturing execution system) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Additional information provided by the customer indicated the subject is recovering (not ended yet).Based upon medical review, the harm observed in the complaint is anticipated in nature as per the device risk assessment.An assignable cause of anticipated procedural complication will be assigned to the reported ¿ patient neurological deficit¿ as a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labeling and/or risk documentation files.
 
Event or Problem Description
It was reported that, the subject flow diverter stent was successfully implanted in the patient on (b)(6) 2023.Post procedure on (b)(6) 2023 patient experienced blurred vision in the right eye.The rationale for relationship to the study device was indicated as: "the stent covered the ophthalmic nerve".It is indicated that the blurred vision is possibly related to the study procedure and the study device.The adverse event outcome is indicated as recovering/resolving and no treatment was provided to the patient for this adverse event.The mrs (modified rankin score) & nihss (national institute of health stroke scale) score noted was '0' at discharge on (b)(6) 2023.The mrs score of 1, nihss score of 3 score was noted on (b)(6) 2023.It is noted that the patient has a past medical history of hypertension, former smoker, localized headache, severe head trauma, depression/anxiety, diabetes, hearing loss, budd-chiari syndrome, kyphoscoliosis, peripheral venous insufficiency and craniotomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURPASS EVOLVE 4.5MM X 17MM - PMAS
Common Device Name
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key18044839
Report Number3008881809-2023-00525
Device Sequence Number7468560
Product Code OUT
UDI-Device Identifier07613327386639
UDI-Public07613327386639
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P170024/S003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/18/2025
Device Catalogue NumberFDS45017
Device Lot Number23973328
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/13/2023
Supplement Date Received by Manufacturer11/09/2023
Initial Report FDA Received Date11/01/2023
Supplement Report FDA Received Date11/16/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/20/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age55 YR
Patient SexFemale
-
-